Robert Williams

Technologies

• Efficient 3D printing manufacturing platform for poorly soluble drugs
• Use of drug solvates in thermal processes to make solid dispersions at lower processing temperature
• Processes and compositions to expand drug processing
• 3D printing technology for customized pharmaceutical dosage forms
• Enzyme delivery for lung injuries and infections using nebulized solutions and perfluorocarbons
• Advanced hot melt extrusion (HME) technology with reduced decomposition
• Individualized intranasal delivery system for direct pharmaceutical administration to the brain
• Advanced nanoparticle delivery system for targeted pulmonary administration of therapeutic nucleic acids
• Solvent-free enhanced 3D printing of biologics
• Thin film freezing technology for stable dry formulations of mRNA therapeutics
• KinetiSol powder ejection for low-temperature formulation of thermolabile APIs
• Dry powder cell formulations for long-term viability and therapeutic applications
• Microneedle array coating technology for enhanced stability and targeted delivery of mRNA and biologics
• Thin-film freeze-dried antibiotic powders for fixed-dose pulmonary delivery